Rituximab Sc Vs Rituximab Iv for non-Hodgkin’s Lymphomas (Nhls)- an Economic Evaluation for the Greek Healthcare System
Abstract
Authors
K Athanasakis L Papageorgiou V Tsiantou A Petropoulou N Boubouchairopoulou F Tarantilis F Theodoropoulou J Kyriopoulos